Umbilical cord blood cells for lung damage after chest radiation
Part of Injuries & trauma, Lungs & breathing clinical trials.
This early-phase trial tests whether special cells from umbilical cord blood, called UCB-MNCs, can help repair lung damage caused by past radiation therapy to the chest. If you have not responded to usual treatments, this may be a new option to explore.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have received radiation therapy to your chest in the past.
- You have been diagnosed with moderate to severe lung damage from that radiation (grade 2 or 3).
- Your lung symptoms have not improved after trying standard treatments for at least 2 weeks.
- Your cancer has been stable or well-controlled for at least 3 months.
- You are not pregnant or breastfeeding, and you don't have serious heart problems, active infections like hepatitis or HIV, or major mental health issues that would interfere with treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a new cell therapy can help people with long-term intestinal damage caused by pelvic or abdominal radiation. It aims to reduce symptoms like diarrhea, pain, or bleeding and improve quality of life.
This trial tests a treatment made from human umbilical cord stem cells for people with moderate ARDS. The goal is to see if it is safe and well-tolerated, and if it might help the lungs recover faster.
This study looks at cells from the lungs of people who developed lung inflammation after chest radiation for cancer. It aims to understand why some people get this reaction, which may help find better treatments.
This trial tests whether infusing stem cells from umbilical cord blood can help your bone marrow recover and make healthy blood cells again after chemotherapy. The goal is to improve your blood counts and reduce the need for transfusions.
This trial studies transplanting healthy blood-forming cells from an umbilical cord blood donor who is not related to you. It may help people with certain blood cancers, immune disorders, or other serious diseases when a standard transplant plan is needed.
This trial tests if adding BIO 300 to chest radiation is safe and helps people who have both non-small cell lung cancer (early stage) and interstitial lung disease (scarring of the lungs). It aims to find better treatment options for this specific group.
Hear when a new Radiation-induced Lung Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.